Exclusive

Publication

Byline

Location

US Patent Issued to HANGZHOU WESTAN PHARMACEUTICAL TECHNOLOGY on June 30 for "N-formamidopyrazoline derivative as P2X3 receptor antagonist and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,589, issued on June 30, was assigned to HANGZHOU WESTAN PHARMACEUTICAL TECHNOLOGY Co. LTD (Hangzhou, China). "N-formamidopyrazoline derivat... Read More


US Patent Issued to VeroScience on June 30 for "Composition and method for treating metabolic disorders" (Rhode Island Inventor)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,590, issued on June 30, was assigned to VeroScience LLC (Tiverton, R.I.). "Composition and method for treating metabolic disorders" was inv... Read More


US Patent Issued to LG Display on June 30 for "Organic light emitting diode and organic light emitting device including the same" (South Korean Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,592, issued on June 30, was assigned to LG Display Co. Ltd. (Seoul, South Korea). "Organic light emitting diode and organic light emitting ... Read More


US Patent Issued to Sichuan Kelun-Biotech Biopharmaceutical on June 30 for "Pyrazole compound and preparation method therefor and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,593, issued on June 30, was assigned to Sichuan Kelun-Biotech Biopharmaceutical Co. Ltd. (Chengdu, China). "Pyrazole compound and preparati... Read More


US Patent Issued to SUDO BIOSCIENCES on June 30 for "TYK2 inhibitors and uses thereof" (American, Indian Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,594, issued on June 30, was assigned to SUDO BIOSCIENCES Ltd. (Altrincham, Great Britain). "TYK2 inhibitors and uses thereof" was invented ... Read More


US Patent Issued to SHANGHAITECH UNIVERSITY, CENTER FOR EXCELLENCE IN MOLECULAR CELL SCIENCE, CHINESE ACADEMY OF SCIENCES on June 30 for "Aza-ergoline derivative and preparation method therefor and application thereof" (Chinese Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,595, issued on June 30, was assigned to SHANGHAITECH UNIVERSITY (Shanghai) and CENTER FOR EXCELLENCE IN MOLECULAR CELL SCIENCE, CHINESE ACAD... Read More


US Patent Issued to RHODES TECHNOLOGIES on June 30 for "Process for crystallizing nalmefene hydrochloride" (Rhode Island Inventor)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,596, issued on June 30, was assigned to RHODES TECHNOLOGIES (Coventry, R.I.). "Process for crystallizing nalmefene hydrochloride" was inven... Read More


US Patent Issued to AURISCO PHARMACEUTICAL (TIANJIN), AURISCO PHARMACEUTICAL on June 30 for "High-purity thienopyrimidine compound and preparation method therefor" (Chinese Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,597, issued on June 30, was assigned to AURISCO PHARMACEUTICAL (TIANJIN) INC. (Tianjin, China) and AURISCO PHARMACEUTICAL Co. LTD. (Taizhou,... Read More


US Patent Issued to Bristol-Myers Squibb on June 30 for "MK2 inhibitors and uses thereof" (Massachusetts, New Jersey Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,598, issued on June 30, was assigned to Bristol-Myers Squibb Co. (Princeton, N.J.). "MK2 inhibitors and uses thereof" was invented by Xirui... Read More


US Patent Issued to Halda Therapeutics OpCo on June 30 for "Heterobifunctional compounds and methods of treating disease" (Connecticut Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,599, issued on June 30, was assigned to Halda Therapeutics OpCo Inc. (New Haven, Conn.). "Heterobifunctional compounds and methods of treat... Read More